Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Can Intense Exercise Modify the Coronary Atherosclerosis Profile?

While physical activity is a widely accepted recommendation for preventing cardiovascular disease, questions remain regarding the impact of very high volumes of exercise. Some studies in endurance athletes have shown a higher burden of coronary plaque—predominantly calcified and stable—while others have reported an increase in non-calcified or mixed plaque, which are associated with higher risk.

This observational, retrospective cohort study evaluated whether high volumes of exercise modify the profile of coronary artery disease detected by computed tomography angiography (CTA) and clinical events, compared to sedentary individuals. Researchers included a total of 224 symptomatic patients (with angina, dyspnea, or pathological studies suggestive of coronary artery disease) without a prior diagnosis of coronary disease, with low or intermediate pre-test probability, referred for CTA in a real-world clinical setting. The study compared 100 patients with high levels of exercise (≥3–5 times per week and ≥1 hour per session; average weekly volume: 9 hours; average MET: 8.78 ± 3.5) with 124 sedentary control subjects. The mean follow-up was 3.95 ± 1.0 years. Only endurance exercise (such as running, cycling, ski mountaineering, or swimming) was considered; strength training, mixed, and low-intensity activities were excluded.

The primary endpoint was the presence of high-risk plaque (HRP); secondary endpoints included coronary artery calcium (CAC) score, stenosis severity (CAD-RADS), major adverse cardiovascular events (MACE), and the need for revascularization. Both groups were comparable in age (56.7 vs. 58.1 years; p=0.328) and dyslipidemia (48% vs. 54%; p=0.393), although athletes had a lower prevalence of hypertension (37% vs. 54%, p=0.016) and diabetes (5% vs. 13.7%, p=0.032), and lower body mass index (24.3 vs. 28.2 kg/m², p <0.001).

There were no significant differences in CAC score (80.5 vs. 107.7 AU; p=0.820), severity of coronary stenosis (p=0.394), or clinical event rates: death (0% vs. 0.8%), acute coronary syndrome (2% vs. 2.4%), and need for revascularization (7% vs. 10.5%; p=0.501). The prevalence of HRP was lower in the high-exercise group (17% vs. 20.9%; p=0.435), but it did not reach statistical significance, and this difference disappeared after adjusting for risk factors.

Read also: Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes.

After matching for all cardiovascular risk factors, multivariate analysis and logistic regression models did not show any association between high levels of exercise and the presence of HRP or elevated CAC.

Conclusion

High levels of exercise (an average of 9 hours per week) are not associated with greater severity of coronary stenosis, higher coronary calcium scores, or increased cardiovascular events. On the contrary, they are associated with lower prevalence of diabetes and hypertension, and lower body mass index. This study confirms that even high volumes of non-professional recreational exercise do not produce adverse effects on coronary morphology or plaque characteristics.

Original Title: The influence of high exercise levels on the coronary atherosclerosis profile by computed tomography angiography and outcomes.

Reference: Gudrun M. Feuchtner et al. American Journal of Preventive Cardiology, 2025; doi:10.1016/j.ajpc.2025.101044.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...